About Inventia Life Science
Inventia Life Science is a company based in Sydney (Australia) founded in 2013 by Cameron Ferris, Julio Ribeiro, and Aidan O'Mahony.. Inventia Life Science has raised $41 million across 5 funding rounds from investors including Superfund, Blackbird Ventures and Skip Capital. Inventia Life Science offers products and services including RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices. Inventia Life Science operates in a competitive market with competitors including Nuclera Nucleics, Aspect Biosystems, CELLINK, Collplant and ROKIT Healthcare, among others.
- Headquarter Sydney, Australia
- Founders Cameron Ferris, Julio Ribeiro, Aidan O'Mahony
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41 M (USD)
in 5 rounds
-
Latest Funding Round
$4.4 M (USD), Series B
Jun 01, 2022
-
Investors
Superfund
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inventia Life Science
Inventia Life Science offers a comprehensive portfolio of products and services, including RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables rapid production of scalable 3D cell models for research.
Provides architectures for managing and analyzing cell models online.
Offers tunable environments for 3D cell culture applications.
Unlock access to complete
Funding Insights of Inventia Life Science
Inventia Life Science has successfully raised a total of $41M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $4.4 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $4.4M
-
First Round
First Round
(01 Jun 2017)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series B - Inventia Life Science | Valuation |
investors |
|
| Dec, 2021 | Amount | Series B - Inventia Life Science | Valuation | Blackbird Ventures | |
| Dec, 2019 | Amount | Series A - Inventia Life Science | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Inventia Life Science
Inventia Life Science has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Superfund, Blackbird Ventures and Skip Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in seed, early, and later-stage tech companies.
|
Founded Year | Domain | Location | |
|
Tech-focused VC firm primarily investing in early to late-stage startups
|
Founded Year | Domain | Location | |
|
Investments are directed toward early-stage tech startups by AirTree.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Inventia Life Science
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Inventia Life Science
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inventia Life Science Comparisons
Competitors of Inventia Life Science
Inventia Life Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, Aspect Biosystems, CELLINK, Collplant and ROKIT Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.
|
|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
4D bio-printer solutions for tissue regeneration are provided.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing pharmaceutical technology platform for drug design
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inventia Life Science
Frequently Asked Questions about Inventia Life Science
When was Inventia Life Science founded?
Inventia Life Science was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is Inventia Life Science located?
Inventia Life Science is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Who is the current CEO of Inventia Life Science?
Julio Ribeiro is the current CEO of Inventia Life Science. They have also founded this company.
Is Inventia Life Science a funded company?
Inventia Life Science is a funded company, having raised a total of $41M across 5 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Jun 01, 2017.
What does Inventia Life Science do?
Inventia Life Science was founded in 2013 in Sydney, Australia, within the biotechnology sector. 3D bio-printers are developed by the company for applications in biomedical research and drug discovery. Human cells are printed using a platform that incorporates natural and synthetic hydrogel bio-inks. This technology supports 3D cell biology studies, including cancer drug testing, through digital bio-printing methods. Operations focus on advancing research tools for scientific and pharmaceutical uses.
Who are the top competitors of Inventia Life Science?
Inventia Life Science's top competitors include Nuclera Nucleics, Aspect Biosystems and Allevi.
What products or services does Inventia Life Science offer?
Inventia Life Science offers RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices.
Who are Inventia Life Science's investors?
Inventia Life Science has 6 investors. Key investors include Superfund, Blackbird Ventures, Skip Capital, AirTree, and Main Sequence.